Stifel analysts upgraded Edwards Lifesciences (NYSE:EW) stock from Hold to Buy, citing potential growth acceleration in the Transcatheter Aortic Valve Replacement (TAVR) market. The firm also ...
Risks to the U.S. stock market are piling up as cracks emerge in the technology trade and the path for interest rates is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback